Scholarlink

<p>Depression is a chronic mental illness that has emerged as the second most prevalent disease globally, characterized by symptoms such as low mood, reduced interest, and cognitive impairment. The onset of depression has been associated with microglial inflammation, but the molecular mechanisms behind this are not well understood. Here, we investigated the mechanisms involved in the roles of microglial inflammation in promoting depression by establishing a mouse model of inflammation-related depression via lipopolysaccharide (LPS) administration. We found that LPS treatment led to microglial activation and increased the deubiquitinating enzyme, USP22, expression in the mouse hippocampus. Further, knockdown of USP22 in microglia inhibited depressive-like behaviors and intracerebral inflammation in the mouse model. Moreover, subsequent mechanistic analyses revealed that KAT2A, which serves as a ubiquitination substrate, is modulated by USP22, thereby influencing mitochondrial damage and oxidative stress in microglia. Our findings indicate that USP22 facilitates oxidative stress and inflammatory responses in microglia through the deubiquitination of KAT2A, providing a promising target for the development of therapeutic strategy for the depression treatment.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Knockdown of USP22 alleviates LPS-induced microglial inflammation and mouse depressive-like behaviors via KAT2A

  • 期刊论文

  • 发表日期：

    2025年8月20日

查看全文
  • Yan Lu,
  • Yuhan Zheng,
  • Xiaoru Sun,
  • Yujie Song,
  • Yilu Zhou,
  • Fuyi Shen,
  • Rongrong Huang,
  • Zhendong Xu

摘要

Depression is a chronic mental illness that has emerged as the second most prevalent disease globally, characterized by symptoms such as low mood, reduced interest, and cognitive impairment. The onset of depression has been associated with microglial inflammation, but the molecular mechanisms behind this are not well understood. Here, we investigated the mechanisms involved in the roles of microglial inflammation in promoting depression by establishing a mouse model of inflammation-related depression via lipopolysaccharide (LPS) administration. We found that LPS treatment led to microglial activation and increased the deubiquitinating enzyme, USP22, expression in the mouse hippocampus. Further, knockdown of USP22 in microglia inhibited depressive-like behaviors and intracerebral inflammation in the mouse model. Moreover, subsequent mechanistic analyses revealed that KAT2A, which serves as a ubiquitination substrate, is modulated by USP22, thereby influencing mitochondrial damage and oxidative stress in microglia. Our findings indicate that USP22 facilitates oxidative stress and inflammatory responses in microglia through the deubiquitination of KAT2A, providing a promising target for the development of therapeutic strategy for the depression treatment.